Evaluating the Efficacy and Safety of Hemofence (Thorombin Cross-Linked Sodium Hyaluronate Gel Matrix) in Hemostasis for Intractable Exudative Bleeding in Spinal Surgery: A Multicenter, Randomized, Phase III Clinical Trial

Objective To demonstrate the noninferiority of the novel hemostatic agent, Hemofence (BMI Korea Co., Ltd., thrombin cross-linked sodium hyaluronate gel matrix) compared to the established agent, Floseal Hemostatic Matrix (Baxter, thrombin-gelatin matrix) in achieving hemostasis for spinal surgeries,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sungjae An, Woo-Keun Kwon, Il Choi, Jang-Bo Lee, Joohyun Kim, Junseok W. Hur
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Spinal Neurosurgery Society 2024-09-01
coleção:	Neurospine
Assuntos:	hemostasis hemofence floseal hyaluronic acid thrombin spin
Acesso em linha:	http://e-neurospine.org/upload/pdf/ns-2448024-012.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!